Oncology Imaging
We use a variety of different tracers on our PET-CT scans to help you get the most accurate cancer imaging results. Here are the different tracers that we use.
Available Tracers:
General tumor tracers:
FDG Tracer
FDG stands for Fâ18 deoxyglucose and is a glucose molecule labeled with radioactive fluorine. Since cancer cells have an increased consumption of glucose, the FDG accumulates in diseased cells. FDG detects numerous tumors and inflammation.
Prostate Cancer Tracers:
PSMA Targeted Tracers
PSMA targeted tracers are a group of new PET/CT imaging tracers that enable the visualization of prostate cancer and its possible metastases in lymph nodes, bones, or organs with exceptional high accuracy. To see the various PSMA tracers that we have available, please click below.
FDG also detects Prostate Cancer.
Neuroendocrine Tumors (NETs):
Somatostatin receptor targeted tracers
Dotatate PET/CT agents are indicated for the localization of Somatostatin Receptor positive neuroendocrine tumors (NETs) in adult patients.
FDG also detects Neuroendocrine cancers.
Breast Cancer Tracers:
Estrogen receptor targeted tracer
Cerianna (fluoroestradiol F18) for PET/CT imaging for the detection of estrogen receptor (ER)-positive lesions as an adjunct to biopsy in patients with recurrent or metastatic breast cancer. We are the first in Westchester county to offer Cerianna.
FDG also detects Breast cancers.
Computed Tomography
An ultra-low-dose Computed Tomography of the lungs (thorax) is recommended for all long-time smokers over the age of 50 in order to visualize any changes (cancer, emphysema, bronchitis) at an early stage.